3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
7
Carcinoma, Transitional Cell
7
Ureteral Neoplasms
3
Urologic Neoplasms
2
Neoplasm Metastasis
2
Urothelial Cancer
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Peripheral Nervous System Diseases
1
Neoplasms by Site
1
Neoplasms
1
Muscle-invasive Bladder Cancer
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Male Urogenital Diseases
1
Female Urogenital Diseases
1
Adenocarcinoma of the Bladder
1
Interventions
Fulvestrant
34
Specimen Handling
31
Letrozole
30
Paclitaxel
23
pembrolizumab
19
Carboplatin
19
ribociclib
18
exemestane
18
Capecitabine
17
Trastuzumab
16
Tamoxifen
16
Magnetic Resonance Spectroscopy
16
palbociclib
15
Anastrozole
15
Biopsy
14
trastuzumab deruxtecan
13
abemaciclib
13
pertuzumab
11
Radiotherapy
11
Cyclophosphamide
9
inavolisib
8
elacestrant
8
olaparib
7
Taxes
7
Standard of Care
7
Radiation
7
Mastectomy, Segmental
7
Goserelin
7
130-nm albumin-bound paclitaxel
7
giredestrant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
enfortumab vedotin
×
30 days
×
Clear all
No trials found.